Corrigendum to “Long non-coding RNA XIST exerts oncogenic functions in human nasopharyngeal carcinoma by targeting miR-34a-5p” [Gene 592(1) (2016) 8–14, (S0378111916305923), (10.1016/j.gene.2016.07.055)];Long non-coding RNA XIST exerts oncogenic functions in human nasopharyngeal carcinoma by targeting miR-34a-5p

Gene

Volumn 592, Issue 1, 2016, Pages 8-14

  Song, Peng ^a   Ye, Lin Feng ^a   Zhang, Cen ^a   Peng, Tao ^a   Zhou, Xu Hong ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

E2F3; Hsa miRNA 34a 5p (miR 34a 5p); Nasopharyngeal carcinoma (NPC); Tumorigenesis; X inactivate specific transcript (XIST)

Indexed keywords

LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA X INACTIVE SPECIFIC TRANSCRIPT; MICRORNA; MICRORNA 34A; MICRORNA 34A 5P; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG; MIRN34 MICRORNA, HUMAN; XIST NON-CODING RNA;

ARTICLE; CELL GROWTH; COLONY FORMATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; LUCIFERASE ASSAY; NASOPHARYNX CARCINOMA; ONCOGENE; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL TIME; TUMOR VOLUME; UPREGULATION; CARCINOMA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NASOPHARYNX TUMOR; TUMOR CELL LINE;

CARCINOMA; CELL LINE, TUMOR; E2F3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; RNA, LONG NONCODING;

EID: 85009843340     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2023.147166     Document Type: Erratum

References (44)

1. Barnhill, L.M., Williams, R.T., Cohen, O., Kim, Y., Batova, A., Mielke, J.A., Messer, K., Pu, M., Bao, L., Yu, A.L., Diccianni, M.B., High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma. Cancer Res. 74 (2014), 3753–3763.
2. Brown, C.J., Ballabio, A., Rupert, J.L., Lafreniere, R.G., Grompe, M., Tonlorenzi, R., Willard, H.F., A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 349 (1991), 38–44.
3. Cai, L.M., Lyu, X.M., Luo, W.R., Cui, X.F., Ye, Y.F., Yuan, C.C., Peng, Q.X., Wu, D.H., Liu, T.F., Wang, E., Marincola, F.M., Yao, K.T., Fang, W.Y., Cai, H.B., Li, X., EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene 34 (2015), 2156–2166.
4. Chang, E.T., Adami, H.O., The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomark. Prev. 15 (2006), 1765–1777.
5. Cooper, C.S., Nicholson, A.G., Foster, C., Dodson, A., Edwards, S., Fletcher, A., Roe, T., Clark, J., Joshi, A., Norman, A., Feber, A., Lin, D., Gao, Y., Shipley, J., Cheng, S.J., Nuclear overexpression of the E2F3 transcription factor in human lung cancer. Lung Cancer 54 (2006), 155–162.
6. Foster, C.S., Falconer, A., Dodson, A.R., Norman, A.R., Dennis, N., Fletcher, A., Southgate, C., Dowe, A., Dearnaley, D., Jhavar, S., Eeles, R., Feber, A., Cooper, C.S., Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene 23 (2004), 5871–5879.
7. Gao, J., Li, N., Dong, Y., Li, S., Xu, L., Li, X., Li, Y., Li, Z., Ng, S.S., Sung, J.J., Shen, L., Yu, J., MiR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Oncogene 34 (2015), 4142–4152.
8. Garzon, R., Volinia, S., Papaioannou, D., Nicolet, D., Kohlschmidt, J., Yan, P.S., Mrozek, K., Bucci, D., Carroll, A.J., Baer, M.R., Wetzler, M., Carter, T.H., Powell, B.L., Kolitz, J.E., Moore, J.O., Eisfeld, A.K., Blachly, J.S., Blum, W., Caligiuri, M.A., Stone, R.M., Marcucci, G., Croce, C.M., Byrd, J.C., Bloomfield, C.D., Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 18679–18684.
9. Geisler, S., Lojek, L., Khalil, A.M., Baker, K.E., Coller, J., Decapping of long noncoding RNAs regulates inducible genes. Mol. Cell 45 (2012), 279–291.
10. Huang, Y.S., Chang, C.C., Lee, S.S., Jou, Y.S., Shih, H.M., Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression. Oncotarget, 2016.
11. Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M.J., Kenzelmann-Broz, D., Khalil, A.M., Zuk, O., Amit, I., Rabani, M., Attardi, L.D., Regev, A., Lander, E.S., Jacks, T., Rinn, J.L., A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142 (2010), 409–419.
12. Humbert, P.O., Verona, R., Trimarchi, J.M., Rogers, C., Dandapani, S., Lees, J.A., E2f3 is critical for normal cellular proliferation. Genes Dev. 14 (2000), 690–703.
13. Kino, T., Hurt, D.E., Ichijo, T., Nader, N., Chrousos, G.P., Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal, 3, 2010, ra8.
14. Ma, M.Z., Chu, B.F., Zhang, Y., Weng, M.Z., Qin, Y.Y., Gong, W., Quan, Z.W., Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis., 6, 2015, e1583.
15. Mercer, T.R., Dinger, M.E., Mattick, J.S., Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 10 (2009), 155–159.
16. Mercer, T.R., Dinger, M.E., Mattick, J.S., Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 10 (2009), 155–159.
17. Nie, F.Q., Zhu, Q., Xu, T.P., Zou, Y.F., Xie, M., Sun, M., Xia, R., Lu, K.H., Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion. Tumour Biol. 35 (2014), 7587–7594.
18. Olsson, A.Y., Feber, A., Edwards, S., Te, P.R., Giddings, I., Merson, S., Cooper, C.S., Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene 26 (2007), 1028–1037.
19. Orom, U.A., Derrien, T., Beringer, M., Gumireddy, K., Gardini, A., Bussotti, G., Lai, F., Zytnicki, M., Notredame, C., Huang, Q., Guigo, R., Shiekhattar, R., Long noncoding RNAs with enhancer-like function in human cells. Cell 143 (2010), 46–58.
20. Pandey, G.K., Mitra, S., Subhash, S., Hertwig, F., Kanduri, M., Mishra, K., Fransson, S., Ganeshram, A., Mondal, T., Bandaru, S., Ostensson, M., Akyurek, L.M., Abrahamsson, J., Pfeifer, S., Larsson, E., Shi, L., Peng, Z., Fischer, M., Martinsson, T., Hedborg, F., Kogner, P., Kanduri, C., The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer Cell 26 (2014), 722–737.
21. Pu, Y., Zhao, F., Wang, H., Cai, W., Gao, J., Li, Y., Cai, S., MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene. Oncotarget, 2016.
22. Rady, B., Chen, Y., Vaca, P., Wang, Q., Wang, Y., Salmon, P., Oberholzer, J., Overexpression of E2F3 promotes proliferation of functional human beta cells without induction of apoptosis. Cell Cycle 12 (2013), 2691–2702.
23. Ren, C., Li, X., Wang, T., Wang, G., Zhao, C., Liang, T., Zhu, Y., Li, M., Yang, C., Zhao, Y., Zhang, G.M., Functions and mechanisms of long noncoding RNAs in ovarian cancer. Int. J. Gynecol. Cancer 25 (2015), 566–569.
24. Salvador, M.A., Wicinski, J., Cabaud, O., Toiron, Y., Finetti, P., Josselin, E., Lelievre, H., Kraus-Berthier, L., Depil, S., Bertucci, F., Collette, Y., Birnbaum, D., Charafe-Jauffret, E., Ginestier, C., The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression. Clin. Cancer Res. 19 (2013), 6520–6531.
25. Sherr, C.J., McCormick, F., The RB and p53 pathways in cancer. Cancer Cell 2 (2002), 103–112.
26. Sun, C., Huang, C., Li, S., Yang, C., Xi, Y., Wang, L., Zhang, F., Fu, Y., Li, D., Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development. Oncotarget, 2016.
27. Sun, C., Li, S., Li, D., Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1. Oncotarget, 2016.
28. Sun, C., Li, S., Yang, C., Xi, Y., Wang, L., Zhang, F., Li, D., MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6. Biochem. Biophys. Res. Commun. 471 (2016), 82–88.
29. Sun, C., Liu, Z., Li, S., Yang, C., Xue, R., Xi, Y., Wang, L., Wang, S., He, Q., Huang, J., Xie, S., Jiang, W., Li, D., Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation. Oncotarget 6 (2015), 25533–25574.
30. Sun, C., Sang, M., Li, S., Sun, X., Yang, C., Xi, Y., Wang, L., Zhang, F., Bi, Y., Fu, Y., Li, D., Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met. Oncotarget 6 (2015), 39756–39792.
31. Sun, C.C., Li, S.J., Yang, C.L., Xue, R.L., Xi, Y.Y., Wang, L., Zhao, Q.L., Li, D.J., Sulforaphane attenuates muscle inflammation in dystrophin-deficient mdx mice via NF-E2-related factor 2 (Nrf2)-mediated inhibition of NF-kappaB signaling pathway. J. Biol. Chem. 290 (2015), 17784–17795.
32. Sun, C.C., Li, S.J., Zhang, F., Pan, J.Y., Wang, L., Yang, C.L., Xi, Y.Y., Li, D.J., Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer. Oncotarget, 2016.
33. Tani, H., Torimura, M., Akimitsu, N., The RNA degradation pathway regulates the function of GAS5 a non-coding RNA in mammalian cells. PLoS One, 8, 2013, e55684.
34. Tantai, J., Hu, D., Yang, Y., Geng, J., Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer. Int. J. Clin. Exp. Pathol. 8 (2015), 7887–7895.
35. Wang, F., Yuan, J.H., Wang, S.B., Yang, F., Yuan, S.X., Ye, C., Yang, N., Zhou, W.P., Li, W.L., Li, W., Sun, S.H., Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology 60 (2014), 1278–1290.
36. Wang, K.C., Chang, H.Y., Molecular mechanisms of long noncoding RNAs. Mol. Cell 43 (2011), 904–914.
37. Yang, F., Huo, X.S., Yuan, S.X., Zhang, L., Zhou, W.P., Wang, F., Sun, S.H., Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol. Cell 49 (2013), 1083–1096.
38. Yang, F., Zhang, L., Huo, X.S., Yuan, J.H., Xu, D., Yuan, S.X., Zhu, N., Zhou, W.P., Yang, G.S., Wang, Y.Z., Shang, J.L., Gao, C.F., Zhang, F.R., Wang, F., Sun, S.H., Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 54 (2011), 1679–1689.
39. Yao, Y., Ma, J., Xue, Y., Wang, P., Li, Z., Liu, J., Chen, L., Xi, Z., Teng, H., Wang, Z., Li, Z., Liu, Y., Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Cancer Lett. 359 (2015), 75–86.
40. Young, J.J., Miller, R.W., Incidence of malignant tumors in U.S. children. J. Pediatr. 86 (1975), 254–258.
41. Yuan, J.H., Yang, F., Wang, F., Ma, J.Z., Guo, Y.J., Tao, Q.F., Liu, F., Pan, W., Wang, T.T., Zhou, C.C., Wang, S.B., Wang, Y.Z., Yang, Y., Yang, N., Zhou, W.P., Yang, G.S., Sun, S.H., A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 25 (2014), 666–681.
42. Yuan, S.X., Wang, J., Yang, F., Tao, Q.F., Zhang, J., Wang, L.L., Yang, Y., Liu, H., Wang, Z.G., Xu, Q.G., Fan, J., Liu, L., Sun, S.H., Zhou, W.P., Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma via de-repression of CTNNB1. Hepatology, 2015.
43. Yuan, S.X., Yang, F., Yang, Y., Tao, Q.F., Zhang, J., Huang, G., Yang, Y., Wang, R.Y., Yang, S., Huo, X.S., Zhang, L., Wang, F., Sun, S.H., Zhou, W.P., Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients’ poor recurrence-free survival after hepatectomy. Hepatology 56 (2012), 2231–2241.
44. Zhuang, L.K., Yang, Y.T., Ma, X., Han, B., Wang, Z.S., Zhao, Q.Y., Wu, L.Q., Qu, Z.Q., MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Cell Death Dis., 7, 2016, e2203.